synthetic oligonucleotides
Twist Bioscience Fiscal Q4 Revenues Jump 27 Percent
The South San Francisco, California-based firm booked $84.7 million in revenues for fiscal Q4 revenues and $313.0 million for FY 2024, both record numbers for the company.
UK Synthetic Genomics Firm Constructive Bio Closes $58M Series A Round
The spinout from Jason Chin's lab at the University of Cambridge offers full-genome synthesis and can expand the genetic code to include non-canonical amino acids.
While the researchers have no plans to sell RNA chips based on the technology, they do intend to commercialize a device for synthesizing high-density arrays.
Twist Bioscience Reports 28 Percent Rise in Fiscal Q3 Revenues, Increases 2024 Guidance
The synthetic DNA maker reported record revenues of $81.5 million, beating the Wall Street estimate on the top line but missing on the bottom line.
Elegen Raises $35M in Series B Financing Round
In a statement, Elegen said it would use the funding to extend its production for clinical development of genetic medicines.